Ultrasound-Guided Suprascapular Nerve Block Versus Intravenous Fentanyl for Analgesia in Patients Presenting to the Emergency Department With Traumatic Scapular Fractures
In brief
Nerve block cut rescue analgesia from 79% to 13% after scapular fractures
In a randomized pilot trial of 60 adults with traumatic scapular fractures, an ultrasound-guided suprascapular nerve block provided stronger pain relief than intravenous fentanyl, with pain scores 4 points lower at 30 and 60 minutes. Only 13% needed rescue analgesia, compared with 79% given fentanyl; larger trials must confirm the results and assess opioid use and longer-term outcomes.
- Journal
- Annals of emergency medicine (Q1)
- Published
- 16 November 2026
- Study design
- Randomized controlled trial
- Evidence level
- Level 1, High (CEBM 1b)
- Authors
- Anmol Chanda, Sanjeev Bhoi, Tej Prakash Sinha, Bharath Gopinath, Ankit Kumar Sahu, Anand Gangdev
- PMID
- 43043325
- DOI
- 10.1016/j.annemergmed.2026.09.009
Why clinicians should know about it
- Picked for Orthopedics and Sports Medicine (paper of the day, 18 November 2026): Randomized trial of analgesia for traumatic scapular fractures
Abstract
STUDY OBJECTIVE: To compare the analgesic efficacy and safety of ultrasound-guided suprascapular nerve block with intravenous fentanyl in patients with traumatic scapular fractures. METHODS: We conducted an open-label randomized controlled pilot trial in the emergency department (ED) of a Level I trauma center in North India. Adults with traumatic scapular fractures and Defense and Veterans Pain Rating Scale scores of 7 and higher, were randomly assigned to ultrasound-guided suprascapular nerve block or intravenous fentanyl (1 μg/kg). Pain scores were assessed at baseline and 30, 60, 120, 240, and 360 minutes. Secondary outcomes included rescue analgesia and adverse events. RESULTS: Sixty patients were randomly assigned to the 2 groups. Median baseline pain score was 10 in both groups. Pain scores were consistently lower with suprascapular nerve block, with median scores of 3 (interquartile [IQR] 2 to 5) versus 7 (IQR 6 to 8) at 30 minutes. Between-group differences were 4 (95% confidence interval [CI], 3 to 4) at 30 and 60 minutes, 2 (95% CI, 2 to 2) at 120 and 240 minutes, and 1 (95% CI, 1 to 2) at 360 minutes. Rescue analgesia was less frequent with suprascapular nerve block (13% versus 79%; risk difference, -66% [95% CI, 47.5 to 85.2]). Drowsiness was more common with fentanyl (12 versus 2 participants); hypotension occurred in 1 fentanyl recipient and paresthesia in 1 suprascapular nerve block recipient. CONCLUSION: In this pilot randomized trial, ultrasound-guided suprascapular nerve block provided greater and sustained pain relief, reduced rescue analgesia, and fewer systemic adverse effects than intravenous fentanyl in adults with traumatic scapular fractures. Larger multicenter trials are needed to confirm these findings and evaluate cumulative opioid use and longer-term outcomes.
Abstract as published, via PubMed.
For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.